» Articles » PMID: 32871756

Deep Sequencing Identified Dysregulated Circulating MicroRNAs in Late Onset Preeclampsia

Overview
Journal In Vivo
Specialty Oncology
Date 2020 Sep 3
PMID 32871756
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: To characterize global microRNA (miRNA) expression profile in the first trimester maternal plasma of women who subsequently develop late-onset preeclampsia (LOPE) compared to uncomplicated pregnancies.

Materials And Methods: Five first trimester plasma samples from women who developed LOPE and 5 controls were analyzed using next generation sequencing technology (NGS) followed by target prediction, Gene Ontology analysis and pathway identification. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed for confirmation in an independent cohort of 12 LOPE cases and 12 controls.

Results: miR-23b-5p and miR-99b-5p were down-regulated by >1.5 fold in LOPE complicated pregnancies (p value <0.05) compared to controls. Target prediction showed that the major targets of these miRNAs are associated with glycometabolism and immune response.

Conclusion: miR-23b-5p and miR-99b-5p are possibly implicated in the pathogenic mechanisms leading to the induction of LOPE and may serve as candidate non-invasive biomarkers for early prediction and prevention.

Citing Articles

Value of Non-Coding RNA Expression in Biofluids to Identify Patients at Low Risk of Pathologies Associated with Pregnancy.

Cordier A, Zerbib E, Favier A, Dabi Y, Darai E Diagnostics (Basel). 2024; 14(7).

PMID: 38611642 PMC: 11011513. DOI: 10.3390/diagnostics14070729.


Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia.

Gal L, Fothi A, Orosz G, Nagy S, Than N, Orban T Front Immunol. 2024; 15:1321191.

PMID: 38455065 PMC: 10917917. DOI: 10.3389/fimmu.2024.1321191.


Circulating miRNAs and Preeclampsia: From Implantation to Epigenetics.

Giannubilo S, Cecati M, Marzioni D, Ciavattini A Int J Mol Sci. 2024; 25(3).

PMID: 38338700 PMC: 10855731. DOI: 10.3390/ijms25031418.


Mitochondrial miR-23b-5p is a new biomarker of warm ischaemic injury in donor livers and a candidate for graft evaluation: experimental studies.

Kong L, Zhou Y, Yuan J, Lv T, Yang J, Shi Y Int J Surg. 2023; 109(7):1880-1892.

PMID: 37184476 PMC: 10389456. DOI: 10.1097/JS9.0000000000000263.


Potential biomarkers for late-onset and term preeclampsia: A scoping review.

Han L, Holland O, da Silva Costa F, Perkins A Front Physiol. 2023; 14:1143543.

PMID: 36969613 PMC: 10036383. DOI: 10.3389/fphys.2023.1143543.


References
1.
Bullard J, Purdom E, Hansen K, Dudoit S . Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010; 11:94. PMC: 2838869. DOI: 10.1186/1471-2105-11-94. View

2.
Lykoudi A, Kolialexi A, Lambrou G, Braoudaki M, Siristatidis C, Papaioanou G . Dysregulated placental microRNAs in Early and Late onset Preeclampsia. Placenta. 2017; 61:24-32. DOI: 10.1016/j.placenta.2017.11.005. View

3.
Anfossi S, Fu X, Nagvekar R, Calin G . MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells. Adv Exp Med Biol. 2018; 1056:87-108. DOI: 10.1007/978-3-319-74470-4_6. View

4.
. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2005; 99(1):159-67. DOI: 10.1016/s0029-7844(01)01747-1. View

5.
. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5):1122-1131. DOI: 10.1097/01.AOG.0000437382.03963.88. View